Exhaustive Extractions

At iuvo, we work hard to stay on the cutting edge of new developments in testing and regulatory changes affecting the medical device and pharmaceutical industries. We will share these updates regularly here in our blog - Exhaustive Extractions.

Dr. Christopher Houston is the Director of Analytical Chemistry at iuvo BioScience. Prior to joining iuvo, Chris was a Senior Principal Scientist at Bausch & Lomb for ten years. In this time, he led the centralized mass spectrometry facility, co-founded and led a collaborative multidisciplinary spectroscopy group focused on scientific problem solving and elucidation of unknown chemical entities, and established Bausch + Lomb’s successful program for Extractables & Leachables (E&L) that extended from new product development to management of post-market packaging changes.


Chris is an world-recognized subject matter expert in E&L, particularly in ophthalmology; a frequent speaker at E&L meetings; and a member of the PQRI Working Group on E&L in Parenteral and Ophthalmic Drug Products (PODP).


Chris began his career at Pharmacia & Upjohn (which later became Pharmacia Corp, then Pfizer) as an analytical project lead responsible for chromatographic method development and validation. In this role, he also created a strategy for E&L in ophthalmic drug products and founded an analytical laboratory focused on solving problems and providing rapid directional studies during pharmaceutical development.


Chris has a B.S. degree in Chemistry from the University of Michigan – Flint where he was involved in a drug-design research program involving chemical synthesis and characterization of the products by cyclic voltammetry and mass spectrometry. He holds a PhD in Analytical Chemistry with a minor in Biochemistry from Indiana University – Bloomington where he utilized matrix-assisted laser desorption / ionization time-of-flight mass spectrometry (MALDI-TOFMS) to study chemical modifications of proteins in the solving of biochemical problems.


Chris is a 1600+ hour instrument-rated private pilot and lives in the Rochester area with his wife, a music teacher, and daughter.

Prior to co-founding iuvo BioScience and taking on the roles of President and CEO, Ben was Vice President of Quality for the Pharmaceutical, Solutions and External Manufacturing organizations of Valeant Pharmaceuticals. Prior to the acquisition of Bausch + Lomb by Valeant, Ben served as Global VP of Quality for the Pharmaceutical Business Unit, and was a member of the B+L Global Leadership Team.


Earlier in his career, he held the position of Director, Quality and Technical Services for Norwich Pharmaceuticals (a contract manufacturing and development organization), responsible for driving new business development and revenue and leading the technical services organization (project managers, engineers, formulators, method developers, etc.) in delivering customer projects, as well as heading up the site quality organization. Ben began his career with Procter & Gamble Pharmaceuticals as a Process Engineer, moving up to roles of increasing responsibility in Product Development, OTC Engineering (Cayey, PR) and Global Clinical Supplies.


Ben holds a BS from Carnegie Mellon University with a double major in Chemical Engineering and Biomedical Engineering, and a dual MS/MAT in Chemistry and Education from Binghamton University.

Dan O’Mara is a Principal Quality Engineer at iuvo BioScience. He holds a Master’s degree in Regulatory Affairs from Johns Hopkins University and a Bachelor’s degree in Environmental Science with a minor in Chemistry from the University of Rochester.


Dan has over 9 years of experience in the pre-clinical evaluation of medical devices for biological safety. During his career, he has held a variety of positions including that of a Research Scientist in Nonclinical Safety and a Manager of Regulatory Affairs.